• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effectiveness of single dose oral dexamethasone versus multidose prednisolone for treatment of acute exacerbations of asthma among children.单剂量口服地塞米松与多剂量泼尼松龙治疗儿童哮喘急性加重的疗效比较
Ann Med Surg (Lond). 2022 Nov 8;84:104799. doi: 10.1016/j.amsu.2022.104799. eCollection 2022 Dec.
2
A Randomized Trial of Single-Dose Oral Dexamethasone Versus Multidose Prednisolone for Acute Exacerbations of Asthma in Children Who Attend the Emergency Department.急诊科就诊的儿童哮喘急性加重期单剂量口服地塞米松与多剂量泼尼松龙对比的随机试验
Ann Emerg Med. 2016 May;67(5):593-601.e3. doi: 10.1016/j.annemergmed.2015.08.001. Epub 2015 Oct 14.
3
Different oral corticosteroid regimens for acute asthma.用于急性哮喘的不同口服皮质类固醇治疗方案。
Cochrane Database Syst Rev. 2016 May 13;2016(5):CD011801. doi: 10.1002/14651858.CD011801.pub2.
4
Single dose oral dexamethasone versus multi-dose prednisolone in the treatment of acute exacerbations of asthma in children who attend the emergency department: study protocol for a randomized controlled trial.单剂量口服地塞米松与多剂量泼尼松龙治疗急诊科就诊的儿童哮喘急性发作的比较:一项随机对照试验的研究方案。
Trials. 2012 Aug 21;13:141. doi: 10.1186/1745-6215-13-141.
5
Two regimens of dexamethasone versus prednisolone for acute exacerbations in asthmatic Egyptian children.两种地塞米松方案与泼尼松龙方案治疗埃及哮喘儿童急性加重的比较。
Eur J Hosp Pharm. 2020 May;27(3):151-156. doi: 10.1136/ejhpharm-2018-001707. Epub 2018 Nov 10.
6
Comparative effectiveness of oral dexamethasone vs. oral prednisolone for acute exacerbation of asthma: A randomized control trial.口服地塞米松与口服泼尼松龙治疗哮喘急性加重的比较效果:一项随机对照试验。
J Family Med Prim Care. 2022 Apr;11(4):1395-1400. doi: 10.4103/jfmpc.jfmpc_1210_21. Epub 2022 Mar 18.
7
Randomized trial of single-dose intramuscular dexamethasone compared with prednisolone for children with acute asthma.单剂量肌内注射地塞米松与泼尼松龙治疗儿童急性哮喘的随机试验。
Pediatr Emerg Care. 2007 Aug;23(8):521-7. doi: 10.1097/PEC.0b013e318128f821.
8
Randomized Trial of Dexamethasone Versus Prednisone for Children with Acute Asthma Exacerbations.地塞米松与泼尼松治疗儿童急性哮喘加重期的随机试验
J Pediatr. 2017 Dec;191:190-196.e1. doi: 10.1016/j.jpeds.2017.08.030.
9
A 3-day course of 1 mg/kg versus 2 mg/kg bodyweight prednisolone for 1- to 5-year-old children with acute moderate exacerbation of asthma: a randomized double-blind noninferiority trial.针对1至5岁哮喘急性中度加重儿童,采用1毫克/千克与2毫克/千克体重的泼尼松龙进行为期3天的治疗:一项随机双盲非劣效性试验。
Paediatr Child Health. 2020 Jul 28;26(4):e189-e193. doi: 10.1093/pch/pxaa082. eCollection 2021 Jul.
10
Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma.肌肉注射与口服皮质类固醇用于减少急性哮喘患者从急诊科出院后的复发情况。
Cochrane Database Syst Rev. 2018 Jun 2;6(6):CD012629. doi: 10.1002/14651858.CD012629.pub2.

引用本文的文献

1
Analysis of the asthma scores recommended in guidelines for children presenting to the emergency department: a Pediatric Emergency Research Networks study.急诊科儿童哮喘评分指南推荐分析:一项儿科急诊研究网络的研究。
Arch Dis Child. 2025 May 16;110(6):422-428. doi: 10.1136/archdischild-2024-327635.

本文引用的文献

1
Randomized Trial of Dexamethasone Versus Prednisone for Children with Acute Asthma Exacerbations.地塞米松与泼尼松治疗儿童急性哮喘加重期的随机试验
J Pediatr. 2017 Dec;191:190-196.e1. doi: 10.1016/j.jpeds.2017.08.030.
2
A Randomized Trial of Single-Dose Oral Dexamethasone Versus Multidose Prednisolone for Acute Exacerbations of Asthma in Children Who Attend the Emergency Department.急诊科就诊的儿童哮喘急性加重期单剂量口服地塞米松与多剂量泼尼松龙对比的随机试验
Ann Emerg Med. 2016 May;67(5):593-601.e3. doi: 10.1016/j.annemergmed.2015.08.001. Epub 2015 Oct 14.
3
Risk factors of childhood asthma in children attending Lyari General Hospital.就读于利亚里综合医院儿童的儿童期哮喘危险因素。
J Pak Med Assoc. 2015 Jun;65(6):647-50.
4
The Impact of Multimedia Education on Knowledge and Self-efficacy among Parents of Children with Asthma: A Randomized Clinical Trial.多媒体教育对哮喘患儿家长知识水平和自我效能的影响:一项随机临床试验。
J Caring Sci. 2014 Sep 1;3(3):185-92. doi: 10.5681/jcs.2014.020. eCollection 2014 Sep.
5
Is dexamethasone an effective alternative to oral prednisone in the treatment of pediatric asthma exacerbations?地塞米松在治疗儿童哮喘急性发作方面是口服泼尼松的有效替代药物吗?
Hosp Pediatr. 2014 May;4(3):172-80. doi: 10.1542/hpeds.2013-0088.
6
Dexamethasone for acute asthma exacerbations in children: a meta-analysis.地塞米松治疗儿童哮喘急性加重症:一项荟萃分析。
Pediatrics. 2014 Mar;133(3):493-9. doi: 10.1542/peds.2013-2273. Epub 2014 Feb 10.
7
Single dose oral dexamethasone versus multi-dose prednisolone in the treatment of acute exacerbations of asthma in children who attend the emergency department: study protocol for a randomized controlled trial.单剂量口服地塞米松与多剂量泼尼松龙治疗急诊科就诊的儿童哮喘急性发作的比较:一项随机对照试验的研究方案。
Trials. 2012 Aug 21;13:141. doi: 10.1186/1745-6215-13-141.
8
Severe asthma in childhood: recent advances in phenotyping and pathogenesis.儿童严重哮喘:表型和发病机制的最新进展。
Curr Opin Allergy Clin Immunol. 2012 Apr;12(2):193-201. doi: 10.1097/ACI.0b013e32835090ac.
9
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.CONSORT 2010 声明:平行组随机试验报告的更新指南。
BMC Med. 2010 Mar 24;8:18. doi: 10.1186/1741-7015-8-18.
10
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.急诊科治疗小儿哮喘急性发作时口服地塞米松与口服泼尼松的比较。
Clin Pediatr (Phila). 2008 Oct;47(8):817-23. doi: 10.1177/0009922808316988. Epub 2008 May 8.

单剂量口服地塞米松与多剂量泼尼松龙治疗儿童哮喘急性加重的疗效比较

Effectiveness of single dose oral dexamethasone versus multidose prednisolone for treatment of acute exacerbations of asthma among children.

作者信息

Tayyab Asma, Asif Alvina, Qazi Shaista, Wahid Sughra, Zafar Anam, Halim Michael, Hussain Irshad, Mumtaz Hassan

机构信息

Senior Registrar Paediatrics, Islamabad Medical and Dental College, Pakistan.

Head of Department Paediatrics, KRL Hospital Islamabad, Pakistan.

出版信息

Ann Med Surg (Lond). 2022 Nov 8;84:104799. doi: 10.1016/j.amsu.2022.104799. eCollection 2022 Dec.

DOI:10.1016/j.amsu.2022.104799
PMID:36536728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9758287/
Abstract

INTRODUCTION

Asthma is one of the most common chronic diseases in children and worldwide its prevalence has increased dramatically in the last three decades. We aimed to compare single dose oral dexamethasone versus multiple doses of oral prednisolone in children with acute exacerbation of asthma in terms of post treatment requirement of systemic steroids.

MATERIALS AND METHODS

This Randomized control trial has been conducted in the Department of paediatrics, KRL Hospital, Islamabad from Dec 2018 to June 2019.312 patients between the age of 2-12 years patients were randomized into Group A receiving a STAT single dose of oral dexamethasone 0.3 mg/kg and Group B receiving prednisolone 1 mg/kg/day followed by two doses on Day 2 and 3. further dose of systemic steroids were ascertained through PRAM score.

RESULTS

In this study mean age in Group A was 8 years with SD ± 5.68 while mean age in Group B was 7 years with SD ± 6.12. In Group A 58% patients were male and 42% patients were female. Whereas in Group B 59% patients were male and 41% patients were female. In Group A 12% patients had further requirement of systemic steroids while in Group B 18% patients had further requirement of systemic steroids while 82% patients didn't had further requirement of systemic steroids.

CONCLUSION

Our study concludes that post treatment requirement of systemic steroids is less in single dose oral dexamethasone as compare to multiple doses of oral prednisolone in children with acute exacerbation of asthma.

摘要

引言

哮喘是儿童中最常见的慢性疾病之一,在全球范围内,其患病率在过去三十年中急剧上升。我们旨在比较单剂量口服地塞米松与多剂量口服泼尼松龙对哮喘急性加重患儿全身用类固醇激素治疗后的需求情况。

材料与方法

本随机对照试验于2018年12月至2019年6月在伊斯兰堡KRL医院儿科进行。312例年龄在2至12岁的患者被随机分为A组,接受单次口服地塞米松0.3mg/kg,B组接受泼尼松龙1mg/kg/天,随后在第2天和第3天各服用两剂。通过PRAM评分确定全身用类固醇激素的进一步剂量。

结果

本研究中,A组的平均年龄为8岁,标准差±5.68,而B组的平均年龄为7岁,标准差±6.12。A组中58%的患者为男性,42%为女性。而B组中59%的患者为男性,41%为女性。A组中12%的患者需要进一步使用全身用类固醇激素,而B组中18%的患者需要进一步使用全身用类固醇激素,82%的患者不需要进一步使用全身用类固醇激素。

结论

我们的研究得出结论,对于哮喘急性加重的儿童,单剂量口服地塞米松治疗后全身用类固醇激素的需求比多剂量口服泼尼松龙少。